Pitfalls and Challenges to Consider before Setting up a Lung Cancer Intensity-modulated Radiotherapy Service: A Review of the Reported Clinical Experience

Clinical Oncology : a Journal of the Royal College of Radiologists
R K ShrimaliS Chatterjee

Abstract

Intensity-modulated radiotherapy (IMRT) is being increasingly used for the treatment of non-small cell lung cancer (NSCLC), despite the absence of published randomised controlled trials. Planning studies and retrospective series have shown a decrease in known predictors of lung toxicity (V20 and mean lung dose) and the maximum spinal cord dose. Potential dosimetric advantages, accessibility of technology, a desire to escalate dose or a need to meet normal organ dose constraints are some of the factors recognised as supporting the use of IMRT. However, IMRT may not be appropriate for all patients being treated with radical radiotherapy. Unique problems with using IMRT for NSCLC include organ and tumour motion because of breathing and the potential toxicity from low doses of radiotherapy to larger amounts of lung tissue. Caution should be exercised as there is a paucity of prospective data regarding the efficacy and safety of IMRT in lung cancer when compared with three-dimensional conformal radiotherapy and IMRT data from other cancer sites should not be extrapolated. This review looks at the use of IMRT in NSCLC, addresses the challenges and highlights the potential benefits of using this complex radiotherapy technique.

References

Oct 1, 1990·Physics in Medicine and Biology·T BortfeldW Schlegel
Dec 21, 2000·International Journal of Radiation Oncology, Biology, Physics·A PirzkallJ Debus
Nov 13, 2001·International Journal of Radiation Oncology, Biology, Physics·UNKNOWN Intensity Modulated Radiation Therapy Collaborative Working Group
Dec 4, 2001·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·K S ChaoG Spector
Aug 8, 2002·Physics in Medicine and Biology·Thomas BortfeldSteve B Jiang
Jul 23, 2003·Physics in Medicine and Biology·Steve B JiangGeorge T Y Chen
Nov 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·David J BrennerMarco Zaider
Mar 6, 2004·International Journal of Radiation Oncology, Biology, Physics·Hasan MurshedJoe Y Change
Mar 6, 2004·International Journal of Radiation Oncology, Biology, Physics·H Helen LiuRadhe Mohan
Mar 31, 2004·International Journal of Radiation Oncology, Biology, Physics·David P GiergaChristopher G Willett
Apr 28, 2004·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Suresh SenanUNKNOWN Radiotherapy Group of European Organization for Research and Treatment of Cancer
Jul 6, 2004·International Journal of Radiation Oncology, Biology, Physics·Jatinder R PaltaMarcia M Urie
Apr 19, 2006·International Journal of Radiation Oncology, Biology, Physics·Eric J Hall
Apr 19, 2006·International Journal of Radiation Oncology, Biology, Physics·Olivier ChapetRandall K Ten Haken
Aug 29, 2006·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Olivier ChapetFrancoise Mornex
Nov 28, 2006·International Journal of Radiation Oncology, Biology, Physics·Sarah M McGuireShiva K Das
Dec 8, 2006·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Elisabeth WeissPaul J Keall
Dec 26, 2006·International Journal of Radiation Oncology, Biology, Physics·Judith A ChristianMichael Brada
May 12, 2007·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Konstantin LavrenkovMichael Brada
Mar 18, 2008·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Sonal SuraKenneth E Rosenzweig
Aug 12, 2008·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Giovanni Mauro CattaneoRiccardo Calandrino
Nov 11, 2008·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Konstantin LavrenkovMichael Brada
Jul 21, 2009·International Journal of Radiation Oncology, Biology, Physics·Timothy HolmesUNKNOWN FASTRO
Feb 2, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J FerlayE Steliarova-Foucher
Nov 16, 2010·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·René MonshouwerHenk Huizenga
Nov 17, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dirk De RuysscherSuresh Senan
Jan 1, 2007·Biomedical Imaging and Intervention Journal·S YartsevJ Van Dyk
Sep 13, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Oscar S H ChanAnne W M Lee
Oct 4, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Jason St-HilaireDaniel Tremblay
Nov 15, 2011·International Journal of Radiation Oncology, Biology, Physics·Zhi-Qin JiangZhongxing Liao
Nov 22, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Anna SimeonovaFrank Lohr
Jun 26, 2012·Clinical Oncology : a Journal of the Royal College of Radiologists·A BezjakUNKNOWN Members of the IMRT Indications Expert Panel
May 8, 2013·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Wilma UyterlindeMichel van den Heuvel
Sep 11, 2013·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Shervin M ShirvaniBenjamin D Smith
Oct 1, 2013·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Chun ChenJosé Belderbos
Oct 8, 2013·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Omar S DinMatthew Q F Hatton
Oct 23, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Donald M CannonGeorge M Cannon
May 6, 2014·Clinical Oncology : a Journal of the Royal College of Radiologists·M WarrenC Faivre-Finn

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Oncology Reports
Laurie E Gaspar, Meisong Ding
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
L ClaudeChristian Carrie
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
José S A BelderbosJoos V Lebesque
© 2021 Meta ULC. All rights reserved